Sinopharm Said to Mull $4 Billion China TCM Take-Private Bid (2)

China National Pharmaceutical Group Co. is considering a revived bid for China Traditional Chinese Medicine Holdings Co. that could value the Hong Kong-listed drugmaker at around $4 billion, people with knowledge of the matter said.

The state-backed firm known as Sinopharm, which holds a controlling stake in China TCM, is talking with advisers about a new offer to potentially take the company private, the people said, after pulling a previous attempt last year. Sinopharm and its advisers are discussing a potential offer of about HK$6 for each China TCM share, while no final decision has been made, the people said. ...